Accuray

Highlights

Mission: Develop personalized, leading-edge treatment solutions that help cancer patients live longer, better lives. More >

Outcome Data: First published five-year outcomes on low risk prostate cancer patients treated with the CyberKnife System. More >

AERO: Accuray Exchange in Radiation Oncology provides a global forum for members to exchange their CyberKnife and TomoTherapy experiences. More >

Accuray Incorporated

Accuray is the premier radiation oncology company. The company develops, manufactures and sells personalized, leading-edge treatment solutions that revolve around the patient. Accuray’s innovative technologies – the CyberKnife and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives.

CyberKnife® Robotic Radiosurgery System

The CyberKnife System is the world’s only non-invasive robotic radiosurgery system treating tumors anywhere in the body. Continual image guidance technology and robotic mobility tracks, detects and corrects for tumor and patient movement during treatment. High-dose radiation and pinpoint precision minimizes damage to healthy tissue eliminating the need for stabilization frames.

TomoTherapy® System

The TomoTherapy® System establishes a gold standard for radiation therapy, combining revolutionary design, industry-leading treatment precision and daily image guidance for true treatment accuracy. The highly integrated TomoTherapy System assures clinicians and patients that treatments are delivered precisely and safely.